Aqst stock forecast the AQST stock forecast scenario for Q2

The AQST stock forecast scenario for Q2 2024 aligns with analyst models projecting a 15% YoY revenue increase, driven by enhanced licensing deals. Traders see $3.20 as the next test level. It is also worth noting that we have found 3 warning signs for Aquestive Therapeutics (2 can't be ignored!) that you need to take into consideration. Libervant can make your child sleepy or dizzy and can slow your child’s thinking and motor skills. As volatility dominates the biotech space, AQST stock forecast sees increased hedge fund positioning. Options market activity points to a higher implied move into earnings season.